Occam Places Paul Audhya as CMO of KalVista
KalVista Pharmaceuticals is a public pharmaceutical company which has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME).
In May 2021 Occam placed Paul Audhya, MD as its CMO. Audhya has over 20 years of clinical development and global medical affairs leadership experience. He previously served as Senior Vice President, Global Medical Affairs at Arena Pharmaceuticals. Prior to Arena, Dr. Audhya held positions of increasing responsibility across all stages of drug development at Vertex Pharmaceuticals, Hospira, Reata Pharmaceuticals, Abbott Labs, Amgen, Bristol Myers Squibb and Janssen.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.